Sumpatan, Noralyn T.
HRN: 23-18-32 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2023
CEFUROXIME 1.5GM (VIAL)
06/19/2023
06/21/2023
IV
1.5gms
Q8hrs
Meconium Stained Amniotic Fluid; Leucocytosis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes